Drug-induced agranulocytosis: Case series
Introduction: Agranulocytosis is a life-threatening disorder characterized by disappearance of granulocytes from peripheral blood or decrease of peripheral neutrophil count below 0.5x109 /l. It frequently occurs as idiosyncratic adverse drug reaction. It occurs especially in association with the use...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Srpsko lekarsko drustvo
2018-01-01
|
Series: | Hospital Pharmacology |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/2334-9492/2018/2334-94921803680C.pdf |
id |
doaj-cd9c6e94297f4181b81bcf532b1c0aea |
---|---|
record_format |
Article |
spelling |
doaj-cd9c6e94297f4181b81bcf532b1c0aea2020-11-24T22:43:58ZengSrpsko lekarsko drustvoHospital Pharmacology2334-94922334-94922018-01-01536806862334-94921803680CDrug-induced agranulocytosis: Case seriesČolović Nataša R.0Leković Danijela R.1Stojković-Lalošević Milica LJ.2Clinic of Hematology, Clinical Center of Serbia, Belgrade + University Belgrade, Medical Faculty, BelgradeClinic of Hematology, Clinical Center of Serbia, Belgrade + University Belgrade, Medical Faculty, BelgradeClinical Center of Serbia, Clinic of gastroenterology and hepatology, BelgradeIntroduction: Agranulocytosis is a life-threatening disorder characterized by disappearance of granulocytes from peripheral blood or decrease of peripheral neutrophil count below 0.5x109 /l. It frequently occurs as idiosyncratic adverse drug reaction. It occurs especially in association with the use of antithyroid drugs, metamizole, aminopyrine and clozapine. The patients usually present with severe acute infections and sepsis. With modern management of broad-spectrum antibiotics and hematopoietic growth factors (G-CSF) the prognosis has been significantly improved. Methods and results: We present 15 patients with drug-induced agranulocytosis, discuss the criteria for diagnosis, management and prognosis. Median patients age was 36 years (ranging from 25 to 61 years). The male/female ratio was 2/13. Underlying diseases were found in 10/15 (66.6%) patients, consisting of hyperthyreosis in 7 (46.6%) patients, mental disorders in 2 patients (13.3%) and in 1 (6.6%) patient suffering from perianalfistula. Nadir median neutrophil count was 0.3x109 /l, range 0-0.5x109 /l, hemoglobin was between 104 and 128 g/L, anaemia was present in 6 (54.5%) patients, platelet count was between 170 and 230x109 /l. The treatment consisted of broad spectrum antibiotics, hematopoietic growth factor in 10, and antimycotic fluconazole in 3 patients. The outcome was favorable in 14 (93.3%) patients and 1 patient who had thyreotoxic crisis and agranulocytosis died. After 4 months, 1 (6.6%) patient, who had a complete recovery from agranulocytosis, developed an acute myeloid leukemia and died. Conclusions: Drug-induced agranulocytosis is a rare haematological complication, with stable incidence and mortality rate of 5% to 10%. The responsible drug for agranulocytosis must be identified, discontinued and permanently contraindicated.https://scindeks-clanci.ceon.rs/data/pdf/2334-9492/2018/2334-94921803680C.pdfagranulocytosisidiosyncratic reactioninfectionhematopoietic growth factors |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Čolović Nataša R. Leković Danijela R. Stojković-Lalošević Milica LJ. |
spellingShingle |
Čolović Nataša R. Leković Danijela R. Stojković-Lalošević Milica LJ. Drug-induced agranulocytosis: Case series Hospital Pharmacology agranulocytosis idiosyncratic reaction infection hematopoietic growth factors |
author_facet |
Čolović Nataša R. Leković Danijela R. Stojković-Lalošević Milica LJ. |
author_sort |
Čolović Nataša R. |
title |
Drug-induced agranulocytosis: Case series |
title_short |
Drug-induced agranulocytosis: Case series |
title_full |
Drug-induced agranulocytosis: Case series |
title_fullStr |
Drug-induced agranulocytosis: Case series |
title_full_unstemmed |
Drug-induced agranulocytosis: Case series |
title_sort |
drug-induced agranulocytosis: case series |
publisher |
Srpsko lekarsko drustvo |
series |
Hospital Pharmacology |
issn |
2334-9492 2334-9492 |
publishDate |
2018-01-01 |
description |
Introduction: Agranulocytosis is a life-threatening disorder characterized by disappearance of granulocytes from peripheral blood or decrease of peripheral neutrophil count below 0.5x109 /l. It frequently occurs as idiosyncratic adverse drug reaction. It occurs especially in association with the use of antithyroid drugs, metamizole, aminopyrine and clozapine. The patients usually present with severe acute infections and sepsis. With modern management of broad-spectrum antibiotics and hematopoietic growth factors (G-CSF) the prognosis has been significantly improved. Methods and results: We present 15 patients with drug-induced agranulocytosis, discuss the criteria for diagnosis, management and prognosis. Median patients age was 36 years (ranging from 25 to 61 years). The male/female ratio was 2/13. Underlying diseases were found in 10/15 (66.6%) patients, consisting of hyperthyreosis in 7 (46.6%) patients, mental disorders in 2 patients (13.3%) and in 1 (6.6%) patient suffering from perianalfistula. Nadir median neutrophil count was 0.3x109 /l, range 0-0.5x109 /l, hemoglobin was between 104 and 128 g/L, anaemia was present in 6 (54.5%) patients, platelet count was between 170 and 230x109 /l. The treatment consisted of broad spectrum antibiotics, hematopoietic growth factor in 10, and antimycotic fluconazole in 3 patients. The outcome was favorable in 14 (93.3%) patients and 1 patient who had thyreotoxic crisis and agranulocytosis died. After 4 months, 1 (6.6%) patient, who had a complete recovery from agranulocytosis, developed an acute myeloid leukemia and died. Conclusions: Drug-induced agranulocytosis is a rare haematological complication, with stable incidence and mortality rate of 5% to 10%. The responsible drug for agranulocytosis must be identified, discontinued and permanently contraindicated. |
topic |
agranulocytosis idiosyncratic reaction infection hematopoietic growth factors |
url |
https://scindeks-clanci.ceon.rs/data/pdf/2334-9492/2018/2334-94921803680C.pdf |
work_keys_str_mv |
AT colovicnatasar druginducedagranulocytosiscaseseries AT lekovicdanijelar druginducedagranulocytosiscaseseries AT stojkoviclalosevicmilicalj druginducedagranulocytosiscaseseries |
_version_ |
1725693543322746880 |